Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...
In a new study, researchers found that being hospitalized for flu or COVID-19 was linked to a 24 percent increase in later lung cancer risk. Learn how to protect yourself.
A study at the University of Virginia has suggested that severe cases of Covid-19 or flu may create conditions in the lungs ...
A woman from Somerset is urging others to trust their instincts and to continue pushing for medical appointments after an uneasy feeling about her family medical history and a “niggly” cough led to ...
Initially, the doctors thought that it was advanced lung cancer. “I remember getting home from a weekend away and receiving a ...
Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...
Lung cancer remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for a nuanced ...
Please provide your email address to receive an email when new articles are posted on . Patients with small cell lung cancer who had higher levels of detectable ctDNA mutations at diagnosis had worse ...
A research team has discovered a crucial mechanism that underlies chemotherapy resistance and metastasis in small cell lung cancer (SCLC). Their study shows that the silencing of the RASA4 gene ...
Patients with advanced lung cancer had better survival outcomes when they received immunochemotherapy earlier in the day, a randomized trial showed. Morning circulating CD8+ T cells increased in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results